US FDA approves Gilead's once-daily combination pill for HIV treatment
GILD•FDA approves Gilead HIV combination pill
The U.S. Food and Drug Administration has approved Gilead Sciences' once-daily oral combination pill for treatment of adults whose HIV has already been reduced to very low levels, the company said on Thursday.
